Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) is now available.
Shanghai Haohai Biological Technology Co., Ltd. has announced the election of a new board session as the current board’s term is nearing its end. The new board will consist of eleven directors, including a mix of executive, non-executive, and independent non-executive directors. The proposals for re-election are subject to shareholder approval at the upcoming annual general meeting. Additionally, Mr. Zhao Lei, an independent non-executive director, will retire and not seek re-election due to personal reasons. The company has expressed gratitude for Mr. Zhao’s contributions during his tenure.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the biotechnology industry. The company focuses on developing and manufacturing biological products, with a market presence in Hong Kong under the stock code 6826.
Average Trading Volume: 585,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$12.06B
For detailed information about 6826 stock, go to TipRanks’ Stock Analysis page.